Article Details

Dr Reddy's acquires trademark rights of breast cancer drug Primcyv from Pfizer to use in India

Retrieved on: 2023-01-13 15:17:15

Tags for this article:

Click the tags to see associated articles and topics

Dr Reddy's acquires trademark rights of breast cancer drug Primcyv from Pfizer to use in India. View article details on HISWAI: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-acquires-trademark-rights-of-breast-cancer-drug-primcyv-from-pfizer-to-use-in-india/articleshow/96972810.cms

Excerpt

Primcyv is a targeted therapy containing the active constituent palbociclib, a first-in-class CDK 4/6 inhibitor indicated in combination with an ...

Article found on: economictimes.indiatimes.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up